NEW World's first Health Intelligence™ Test Find out more
About Us
Our proven expertise is why Viome is the only private company trusted with exclusive license to technology first developed at the prestigious Los Alamos National Laboratory.
Viome's pioneering artificial learning engines are designed to not only analyze your data, but to aggregate all the biological data we receive. As the sample size grows, our machines will spot trends and influences, which will unlock scientific breakthroughs.
As science points to a link between overall health, our gut organisms, and the genes that are expressed throughout our body, Viome asks: What if the best we feel now is only the beginning of how great our health can be? Our mission is to help people understand what they uniquely need to be healthy and allow them to take back control of their health.
Feel free to reach out at info@viome.com
Naveen Jain
Chief Executive Officer
Naveen is an entrepreneur and philanthropist driven to solve the world’s biggest challenges through innovation.
Guruduth Banavar
Chief Technology Officer
Guru is a leader in Artificial Intelligence and Distributed Systems technologies. He is proud to have led the creation of Watson AI technologies at IBM. He is now excited to apply these technologies to enhance your wellness!
Stephen Barrie
Vice President
Stephen is a physician, scientist and entrepreneur and one of the founding pioneers in the microbiome field. His life has been dedicated to providing tools and information for people to improve their health.
John Blanchard
Chief Operating Officer
John is an eCommerce and Operations leader who has spent the last 20+ years delivering customer-focused experiences on a global scale. He has a background in computer science, bioinformatics, marketing, supply chain, analytics, operations, and most recently held leadership roles at Amazon and Groupon.
Barry Jahansetan
Chief Financial Officer
Barry is a 20 year CFO veteran of Silicon Valley. Barry has deep expertise in the financial management and business operations of SaaS and Biotech businesses. Barry started his career at Ernst & Young as an auditor, has been on multiple IPOs, held management positions with large public COs, and led multiple financings and exits including the sale of Bina Technologies, a genomics informatics company, to Roche.
Ally Perlina
Chief Translational Science Officer
Ally is a systems biology leader and a precision medicine innovator with over 17 years of industry experience, which include working with top world pharma and, more recently, leading analytical efforts for clinical decision support at HLI. She is focused on deriving scientific insights from various “omics” data and systematically “translating” them into personalized interventions for disease treatment and prevention.
Momo Vuyisich
Chief Science Officer
Momo brings more than 25 years of R&D experience in many scientific disciplines. He was most recently a scientist and leader of the Applied Genomics team at Los Alamos National Laboratory, where he successfully managed large national and international collaborations.
Alessio Fasano
W. Allan Walker Chair of Pediatric Gastroenterology and Nutrition, Professor of Pediatrics, Harvard Medical School, Chief of Division of Pediatric Gastroenterology and Nutrition.
Daniel Kraft
Physician-scientist, inventor, entrepreneur, innovator, and Chair of Medicine and Neuroscience at Singularity University.
Andrew McCallum
Andrew McCallum is Professor and Director of the Information Extraction and Synthesis Laboratory, as well as Director of Center for Data Science in the College of Information and Computer Science at University of Massachusetts Amherst.
Ray Kurzweil
Inventor, thinker, computer scientist, entrepreneur, New York Times bestselling author and Google’s Chief Futurist.
Emeran Mayer
Physician-scientist, UCLA Professor of Medicine, Physiology and Psychiatry. Executive Director of G. Oppenheimer Center for Neurobiology of Stress and Resilience, and Co-director of CURE: Digestive Diseases Research Center.
